Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move beyond one-time attacks and short-term memory to become a long-term immunity ...

COPENHAGEN, Denmark, October 8, 2025 - Evaxion A/S (EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, is launching a significant ...

A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic has developed a new artificial intelligence (AI) model that can help ...

A child receives a dose of polio vaccine during a door-to-door vaccination campaign in Karachi on September 9 - Copyright AFP Rizwan TABASSUM A child receives a dose ...

The FDA has cleared Everest Medicine's EVM14 cancer vaccine application, and its EVM16 vaccine has been administered on the first patient under an investigator-initiated trial Everest Medicines has ...

As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death. Even ...

When news of the efficacy of the Covid-19 vaccine was first shared, the medical community was astounded not only by the vaccine’s ability to protect people from infection but also by the speed at ...

HPV (human papillomavirus) infection is incredibly common, with 80% of adults having had it by age 45. It is known to cause several types of cancer, including cancers of the cervix, anus, vagina, ...

Artificial intelligence’s (AI) predictive capabilities will help the vaccine industry optimize manufacturing, reduce production costs, and increase patient access to lifesaving jabs. That, at least, ...